BBOT

BridgeBio Oncology
BBOT

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$25
124% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Andrew Berens
100% 1-yr BBOT win rate
17 Sep ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Robert Burns
100% 1-yr BBOT win rate
15 Sep ‘25 1 month ago
Oppenheimer
Oppenheimer
Matthew Biegler
100% 1-yr BBOT win rate
4 Sep ‘25 1 month ago
Wedbush
Wedbush
David Nierengarten
100% 1-yr BBOT win rate
18 Aug ‘25 2 months ago